Beta Bionics (BBNX) Revenue (2024 - 2026)

Beta Bionics has disclosed Revenue across 3 years of filings, most recently posting $32.0 million for Q2 2026.

• In Q2 2026, Revenue rose 37.76% year-over-year to $32.0 million; the TTM figure through Jun 2026 stood at $119.0 million (up 52.54% YoY), while the FY2025 annual figure was $100.3 million, up 53.94% from the prior year.
• Revenue came in at $32.0 million for Q2 2026 at Beta Bionics, up from $27.6 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $32.1 million in Q4 2025 to a low of $12.9 million in Q1 2024.
• Average Revenue over 3 years is $22.5 million, with a median of $21.8 million recorded in 2024.
• The largest YoY upside for Revenue was 63.14% in 2025 against a maximum downside of 36.39% in 2025.
• Over 3 years, Revenue stood at $20.4 million in 2024, then soared by 57.15% to $32.1 million in 2025, then retreated by 0.34% to $32.0 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $32.0 million in Q2 2026, $27.6 million in Q1 2026, and $32.1 million in Q4 2025.